Comment on Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Pfizer's quarterly revenue fell as generic competition over blockbuster drugs like Viagra cut into sales. And the world's largest drug maker cut its revenue outlook for the full year because it foresees further generic competition eating into another big seller, its $3 billion anti-arthritis drug, Celebrex. It had lost a court ruling that now makes it possible for generic makers like Teva and Mylan to launch their versions in December.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News